LIVE NEWS
  • Bitcoin Near $70,000 as ETFs Improve Bullish Signs
  • Cross-national comparative assessment of synergies and conflicts in climate policy mixes
  • Justice Department restarts program to restore gun rights : NPR
  • HIMSS26: Strengthen the Muscle of AI Strategy With Clinical Insight
  • Google starts rolling out Gemini in Chrome to users in Canada, India and New Zealand
  • Three Ships Hit by Projectiles in Middle East, UK Navy Says – Bloomberg.com
  • Amazon is linking site hiccups to AI efforts
  • Secret of hedgehog hearing discovered at far beyond human range
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • See More
    • Artificial Intelligence
    • Climate Risks
    • Defense
    • Healthcare Innovation
    • Science
    • Technology
    • World
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • Artificial Intelligence
  • Climate Risks
  • Defense
  • Healthcare Innovation
  • Science
  • Technology
  • World
Home»Healthcare Innovation»GOP Sen. Johnson investigating FDA rare disease drug rejections
Healthcare Innovation

GOP Sen. Johnson investigating FDA rare disease drug rejections

primereportsBy primereportsMarch 11, 2026No Comments1 Min Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
GOP Sen. Johnson investigating FDA rare disease drug rejections
Share
Facebook Twitter LinkedIn Pinterest Email


WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease treatments.

The Wisconsin Republican is requesting denial letters, called complete response letters, that the FDA sent to makers of rare disease treatments for conditions including ataxia and Sanfilippo syndrome. He said he’s heard that some of the issues in those letters are “nitpicky things.” 

“We’re going to find out exactly what issues the FDA listed for their ‘nos’,” he said.

STAT+ Exclusive Story

Already have an account? Log in

GOP Sen. Johnson investigating FDA rare disease drug rejections



STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWhat to Do in Chicago If You’re Here for Business (2026)
Next Article ICE says Camp East Montana detention facility staying open, not closing
primereports
  • Website

Related Posts

Healthcare Innovation

HIMSS26: Strengthen the Muscle of AI Strategy With Clinical Insight

March 11, 2026
Healthcare Innovation

AI finally tests a century old theory about how cancer begins

March 11, 2026
Healthcare Innovation

Cloud-Based EHR Systems: Achieving Security & Migration Success

March 10, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Global Resources Outlook 2024 | UNEP

December 6, 20255 Views

The D Brief: DHS shutdown likely; US troops leave al-Tanf; CNO’s plea to industry; Crowded robot-boat market; And a bit more.

February 14, 20264 Views

German Chancellor Merz faces difficult mission to Israel – DW – 12/06/2025

December 6, 20254 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest Reviews

Subscribe to Updates

Get the latest tech news from FooBar about tech, design and biz.

PrimeReports.org
Independent global news, analysis & insights.

PrimeReports.org brings you in-depth coverage of geopolitics, markets, technology and risk – with context that helps you understand what really matters.

Editorially independent · Opinions are those of the authors and not investment advice.
Facebook X (Twitter) LinkedIn YouTube
Key Sections
  • World
  • Geopolitics
  • Popular Now
  • Artificial Intelligence
  • Cybersecurity
  • Crypto
All Categories
  • Artificial Intelligence
  • Climate Risks
  • Crypto
  • Cybersecurity
  • Defense
  • Economy
  • Geopolitics
  • Global Markets
  • Healthcare Innovation
  • Politics
  • Popular Now
  • Science
  • Technology
  • World
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • DMCA / Copyright Notice
  • Editorial Policy

Sign up for Prime Reports Briefing – essential stories and analysis in your inbox.

By subscribing you agree to our Privacy Policy. You can opt out anytime.
Latest Stories
  • Bitcoin Near $70,000 as ETFs Improve Bullish Signs
  • Cross-national comparative assessment of synergies and conflicts in climate policy mixes
  • Justice Department restarts program to restore gun rights : NPR
© 2026 PrimeReports.org. All rights reserved.
Privacy Terms Contact

Type above and press Enter to search. Press Esc to cancel.